Thymulin (FTS-Zn)

Mechanism

A small hormone naturally produced by your thymus gland that requires zinc to function. It's essential for T-cell maturation and immune function, but levels drop dramatically with age as the thymus shrinks. Supplementing thymulin (with zinc) may help restore some immune function in aging. Studied for anti-aging and immune modulation.

Effects

**Immune System (Tier 1 — Well-characterized thymic hormone):** Thymulin (formerly called Facteur Thymique Serique/FTS) is a nonapeptide (9 amino acids: pyroGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn) produced exclusively by thymic epithelial cells. It REQUIRES zinc binding for biological activity — the zinc-thymulin complex is the active form. Thymulin promotes T-cell differentiation in the thymus, induces expression of T-cell markers (CD2, CD3, CD4, CD8) on immature thymocytes, modulates cytokine production (suppresses pro-inflammatory, enhances anti-inflammatory), and enhances NK cell cytotoxicity. **Neuroendocrine System (Tier 2):** Thymulin has direct neuroendocrine effects — crosses the blood-brain barrier and binds to receptors in the hypothalamus. Modulates ACTH, prolactin, and growth hormone secretion. Provides evidence of the thymus-hypothalamus-pituitary axis. In zinc-deficient states, thymulin activity drops precipitously, contributing to the immune dysfunction seen in zinc deficiency. **Zinc Dependency (Tier 1 — Critical Biochemistry):** Thymulin is biologically INERT without bound zinc. Serum thymulin levels decline with age (paralleling thymic involution), but can be partially restored by zinc supplementation alone. This is one of the key mechanisms by which zinc supports immune function — it reactivates circulating thymulin. Zinc-thymulin ratio is a sensitive biomarker of functional immune status. **Anti-inflammatory (Tier 2):** Thymulin suppresses NF-kB signaling in macrophages and dendritic cells. Reduces TNF-alpha, IL-1beta, and IL-6 production. Enhances IL-10 (anti-inflammatory cytokine) production. This dual action — immune stimulation of adaptive immunity + anti-inflammatory modulation of innate immunity — makes it an immune modulator rather than a simple immune stimulant.

Practitioner Guide

**Clinical Protocol:** - Zinc-thymulin is typically administered as a combined zinc + thymulin preparation - Dose: 1-5mg SC or IM daily for 10-20 days, or 2-3x per week for 4-6 weeks - CRITICAL: ensure adequate zinc status — supplement with zinc picolinate or zinc bisglycinate 30-50mg/day alongside thymulin - Many practitioners start with zinc repletion (4-6 weeks of 50mg zinc/day) BEFORE initiating thymulin for maximum efficacy **Functional Medicine Applications:** - Age-related immune decline: thymulin levels decrease ~50% by age 60 — supplementation restores T-cell function markers - Post-infection immune recovery (COVID, EBV, chronic Lyme): 2-5mg SC daily x 10-14 days - Zinc deficiency-related immune dysfunction: thymulin + zinc supplementation - Autoimmune conditions: immunomodulatory profile makes it potentially useful (unlike immunostimulants which can worsen autoimmunity), but clinical data is limited **Important Considerations:** - Thymulin is NOT the same as thymalin (thymalin is a crude thymic extract; thymulin is a defined single peptide) - Not the same as thymosin alpha-1 (different peptide, different mechanism) - Zinc status must be optimized — without adequate zinc, thymulin is pharmacologically inactive - Monitor serum zinc, CBC with differential, T-cell subsets before and during treatment

Dosing Protocols

Contraindications & Cautions

• hard stop — Organ transplant / immunosuppressive therapy
  Thymulin promotes T-cell differentiation and immune activation. In organ transplant recipients, immune stimulation may trigger graft rejection and directly oppose immunosuppressive therapy.
  Action: Absolutely contraindicated in organ transplant recipients and patients on immunosuppressive therapy.
• hard stop — Pregnancy
  No adequate safety data during pregnancy. Immune-modulating peptide could affect maternal-fetal immune tolerance.
  Action: Do not use during pregnancy.
• hard stop — Breastfeeding
  No data on excretion in breast milk. Immune-modulating effects on nursing infant unknown.
  Action: Do not use while breastfeeding.
• hard stop — Under 18 years of age
  Immune-modulating peptide. Not for unsupervised pediatric use.
  Action: Do not provide to individuals under 18.
• requires physician — Autoimmune disease
  Thymulin enhances T-cell function and immune surveillance. May exacerbate autoimmune conditions by amplifying autoreactive T-cell responses.
  Action: Requires specialist evaluation by immunologist or rheumatologist. Monitor autoimmune markers closely.

Evidence

• Role of the low zinc bioavailability on cellular immune effectiveness in cystic fibrosis

  Mocchegiani E, Provinciali M, Di Stefano G, Nobilini A, Caramia G, Santarelli L, Tibaldi A, Fabris N (1995) — Clinical Immunology and Immunopathology — PMID: 7882594

  Low zinc bioavailability in cystic fibrosis patients was associated with reduced thymulin activity and impaired T-cell function. Zinc supplementation restored active thymulin levels and improved cellular immune parameters. Establishes the zinc-thymulin axis as critical for immune competence and suggests therapeutic potential for restoring thymulin activity through zinc repletion in immunocompromised states.

  emerging

• The mode of action of thymic hormones

  Bach JF (1977) — Annals of the New York Academy of Sciences

  Thymulin (formerly facteur thymique serique/FTS), a zinc-dependent nonapeptide produced by thymic epithelial cells, was characterized as essential for T-cell differentiation and maturation. Thymulin levels decline with age and thymic involution. The peptide modulates T-cell subsets, enhances IL-2 production, and regulates immune balance between Th1/Th2 responses. Zinc supplementation can partially restore thymulin activity in zinc-deficient elderly individuals.

  emerging

Stacks featuring this peptide

Research Summary

**Tier 1 — Well-characterized Thymic Hormone:** - Discovered by Bach & Dardenne (1972) as "Facteur Thymique Serique" (FTS) - Fully sequenced and characterized as zinc-dependent nonapeptide - Extensive basic science literature (hundreds of papers) on T-cell differentiation, thymic function, zinc dependency - Thymulin decline with aging is one of the best-documented features of immunosenescence **Tier 2 — Clinical Studies:** - Zinc supplementation restores serum thymulin activity in zinc-deficient elderly (Prasad et al., multiple studies) - Thymulin administration in immunocompromised patients: restoration of T-cell markers and proliferative responses - Zinc-thymulin in Down syndrome: multiple studies showing improvement in T-cell function (these patients have accelerated thymic involution) - Neuroendocrine studies: thymulin modulates hypothalamic-pituitary function (Hadden, Goya et al.) **Tier 3 — Emerging:** - Synthetic zinc-thymulin analogs with improved stability and bioavailability in development - Investigation of thymulin as biomarker for "biological immune age" vs. chronological age - Intranasal thymulin delivery for CNS immunomodulation (animal models of neuroinflammation) - Thymulin gene therapy approaches in animal models of aging